Brief: Sesen Bio - On Nov 17, FDA Granted Co's Request For A Type A Meeting To Discuss Recommendations Regarding CRL

Carisma Therapeutics

18/11/2021 13:21

Nov 18 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO - ON NOV 17, FDA GRANTED CO REQUEST FOR A TYPE A
MEETING TO DISCUSS RECOMMENDATIONS REGARDING CRL FOR CO'S BLA
FOR VICINEUMTM
    * SESEN BIO INC - CLINICAL TYPE A MEETING HAS BEEN SCHEDULED
FOR
DECEMBER 8, 2021

Source text for Eikon:  ID: 
Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))